IM Cannabis Corp. (IMCC)
$1.33
+0.02 (+1.53%)
Rating:
Recommendation:
-
| Symbol | IMCC |
|---|---|
| Price | $1.33 |
| Beta | 2.063 |
| Volume Avg. | 0.04M |
| Market Cap | 13.434M |
| Shares () | - |
| 52 Week Range | 0.821-26.7 |
| 1y Target Est | - |
| DCF Unlevered | IMCC DCF -> | |
|---|---|---|
| DCF Levered | IMCC LDCF -> | |
| ROE | -107.51% | Strong Sell |
| ROA | -131.03% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 134.52% | Buy |
| P/E | - | |
| P/B | 0.22 | Neutral |
Latest IMCC news
About
Download (Excel)Mr. Marc Lustig
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.